U.S. Representative Robert Aderholt, R-Ala., and U.S. Representative Barry Moore, R-Ala., criticized the Food and Drug Administration on Wednesday for approving a generic version of abortion drug, mifepristone.

Mifepristone is a drug prescribed in combination with misoprostol to terminate a pregnancy within the first ten weeks of gestation. The medication has been FDA-approved for 25 years.

The representatives released statements opposing the approval of a generic option for the drug, announced by the FDA on September 2, alleging the drug puts women’s lives at risk with dangerous side effects.

Statements condemning the approval were released by an additional 22 members of the U.S. House Values Action Team, which Aderholt chairs.

“The FDA’s approval of a new generic version of the abort

See Full Page